Discontinued — last reported Q4 '24
Operating
Net gains (losses) on investments
Roivant Sciences Net gains (losses) on investments decreased by 83.2% to $21.59M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 201.3%, from -$21.31M to $21.59M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ4 2024
How to read this metric
Positive values indicate successful investment management, while negative values reflect market volatility or poor asset performance.
Detailed definition
This captures the non-cash gains or losses realized from the sale or revaluation of equity investments and securities. I...
Peer comparison
Common for large corporations with diversified portfolios or strategic minority stakes.
Metric ID:
gain_loss_on_investmentsHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$8.62M | $32.27M | -$38.04M | -$72.91M | -$24.55M | -$54.68M | $25.95M | -$7.56M | -$45.85M | -$10.47M | $15.23M | $48.38M | -$21.31M | $12.90M | -$19.13M | $128.50M | $21.59M |
| QoQ Change | — | +474.4% | -217.9% | -91.7% | +66.3% | -122.7% | +147.5% | -129.2% | -506.1% | +77.2% | +245.5% | +217.7% | -144.1% | +160.5% | -248.3% | +771.9% | -83.2% |
| YoY Change | — | — | — | — | -184.8% | -269.4% | +168.2% | +69.2% | +16.1% | -140.3% | +301.3% | +205.5% | -103.6% | — | -225.6% | +165.6% | +201.3% |
Range-$72.91M – $128.50M
CAGR+25.8%
Avg YoY Growth+17.0%
Median YoY Growth+42.7%
Business Segments
| Segment | Q3 '25 | Q4 '25 |
|---|---|---|
| Reportable Segment | $128.50M | $21.59M |
| Total | $128.50M | $21.59M |
Net gains (losses) on investments at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's net gains (losses) on investments?
- Roivant Sciences (ROIV) reported net gains (losses) on investments of $21.59M in Q4 2025.
- How has Roivant Sciences's net gains (losses) on investments changed year-over-year?
- Roivant Sciences's net gains (losses) on investments increased by 201.3% year-over-year, from -$21.31M to $21.59M.
- What does net gains (losses) on investments mean?
- The profit or loss made from selling or holding financial investments.